Download Bibliographies Recherches dans les pays à ressources

Bibliographies Recherches dans les pays à ressources limitées 2014
Aghokeng A F, Monleau M, Eymard-Duvernay S, Dagnra A, Kania D, Ngo-Giang-Huong N, Toni T D,
Toure-Kane C, Truong L X, Delaporte E, Chaix M L, Peeters M, Ayouba A and Group A S.
Extraordinary heterogeneity of virological outcomes in patients receiving highly antiretroviral therapy
and monitored with the World Health Organization public health approach in sub-saharan Africa and
southeast Asia. Clin Infect Dis, 2014, 58, 99-109 Clinical infectious diseases : an official publication of
the Infectious Diseases Society of America, ANRS 12186
April M D, Wood R, Berkowitz B K, Paltiel A D, Anglaret X, Losina E, Freedberg K A and Walensky R
P. The survival benefits of antiretroviral therapy in South Africa. J Infect Dis, 2014, 209, 491-9 The
Journal of infectious diseases,
Barennes H, Guillet S, Limsreng S, Him S, Nouhin J, Hak C, Srun C, Viretto G, Ouk V, Delfraissy J F
and Segeral O. Virological failure and HIV-1 drug resistance mutations among naive and antiretroviral
pre-treated patients entering the ESTHER program of Calmette Hospital in Cambodia. PLoS One,
2014, 9, e105736 PloS one, Site Cambodge
Bastard M, Fall M B and groupe d'etude de la Cohorte A. [Long term adherence to HAART in
Senegal]. Bull Soc Pathol Exot, 2014, 107, 241-3 Bulletin de la Societe de pathologie exotique, ANRS
1215
Bertrand J, Verstuyft C, Chou M, Borand L, Chea P, Nay K H, Blanc F X, Mentre F, Taburet A M and
Group C S. Dependence of efavirenz- and rifampicin-isoniazid-based antituberculosis treatment drugdrug interaction on CYP2B6 and NAT2 genetic polymorphisms: ANRS 12154 study in Cambodia. J
Infect Dis, 2014, 209, 399-408 The Journal of infectious diseases, ANRS 12154
Bhatt N B, Barau C, Amin A, Baudin E, Meggi B, Silva C, Furlan V, Grinsztejn B, Barrail-Tran A,
Bonnet M, Taburet A M and Group A C S. Pharmacokinetics of rifampin and isoniazid in tuberculosisHIV-coinfected patients receiving nevirapine- or efavirenz-based antiretroviral treatment. Antimicrob
Agents Chemother, 2014, 58, 3182-90 Antimicrobial agents and chemotherapy,
Bhatt N B, Baudin E, Meggi B, da Silva C, Barrail-Tran A, Furlan V, Grinsztejn B, Bonnet M, Taburet A
M and on behalf of the A C S G. Nevirapine or efavirenz for tuberculosis and HIV coinfected patients:
exposure and virological failure relationship. J Antimicrob Chemother, 2014 The Journal of
antimicrobial chemotherapy,
Bonnard P, Elsharkawy A, Zalata K, Delarocque-Astagneau E, Biard L, Le Fouler L, Hassan A B,
Abdel-Hamid M, El-Daly M, Gamal M E, El Kassas M, Bedossa P, Carrat F, Fontanet A and Esmat G.
Comparison of liver biopsy and noninvasive techniques for liver fibrosis assessment in patients
infected with HCV-genotype 4 in Egypt. J Viral Hepat, 2014 Journal of viral hepatitis, ANRS 12184
Borand L, Madec Y, Laureillard D, Chou M, Marcy O, Pheng P, Prak N, Kim C, Lak K K, Hak C, Dim B,
Nerrienet E, Fontanet A, Sok T, Goldfeld A E, Blanc F X and Taburet A M. Plasma concentrations,
efficacy and safety of efavirenz in HIV-infected adults treated for tuberculosis in Cambodia (ANRS
1295-CIPRA KH001 CAMELIA trial). PLoS One, 2014, 9, e90350 PloS one, ANRS1295 / ANRS 12160
CAMELIA
Boufkhed S and Taverne B. [Assessing the direct cost of medical care for HIV between the third and
tenth year of ARV treatment in Dakar]. Bull Soc Pathol Exot, 2014, 107, 292-8 Bulletin de la Societe de
pathologie exotique, ANRS 1215
Boulle C, Rouet F, Fassinou P, Msellati P, Debeaudrap P, Chaix M L, Rouzioux C and AvettandFenoel V. HIV-1 DNA concentrations and evolution among African HIV-1-infected children under
antiretroviral treatment (ANRS 1244/1278). J Antimicrob Chemother, 2014, 69, 3047-50 The Journal
of antimicrobial chemotherapy, ANRS1244/ANRS1278
Breban R, Arafa N, Leroy S, Mostafa A, Bakr I, Tondeur L, Abdel-Hamid M, Doss W, Esmat G,
Mohamed M K and Fontanet A. Effect of preventive and curative interventions on hepatitis C virus
transmission in Egypt (ANRS 1211): a modelling study. The Lancet. Global health, 2014, 2, e541-9 The
Lancet. Global health, ANRS 1211
Breban R and Fontanet A. Feasible HCV targets in Egypt - authors' reply. The Lancet. Global health,
2014, 2, e688 The Lancet. Global health, Site Egypte
Cames C, Cournil A, de Vincenzi I, Gaillard P, Meda N, Luchters S, Nduati R, Naidu K, Newell M L,
Read J S, Bork K and Kesho Bora Study G. Postpartum weight change among HIV-infected mothers
by antiretroviral prophylaxis and infant feeding modality in a research setting. AIDS, 2014, 28, 85-94
Aids, ANRS 1289 KESHO BORA
Cassier M and Correa M. Access to medicines in developing countries: ethical demands and moral
economy. Developing world bioethics, 2014, 14, ii-viii Developing world bioethics,
Cianci F, Sweeney S, Konate I, Nagot N, Low A, Mayaud P and Vickerman P. The cost of providing
combined prevention and treatment services, including ART, to female sex workers in Burkina Faso.
PLoS One, 2014, 9, e100107 PloS one, ANRS 1222
Couderc M and Desclaux Sall C. [Moving from patient information to involvement in associations for
people living with HIV participating in a medical study in Senegal - ANRS cohort 1215]. Bull Soc Pathol
Exot, 2014, 107, 286-91 Bulletin de la Societe de pathologie exotique, ANRS 1215
Coulibaly M, Meda N, Yonaba C, Ouedraogo S, Congo M, Barry M, Thio E, Siribie I, Koueta F, Ye D,
Kam L, Blanche S, Van De Perre P, Leroy V and ANRS M S G. Missed Opportunities for Early Access to
Care of HIV-Infected Infants in Burkina Faso. PLoS One, 2014, 9, e111240 PloS one, ANRS 12206
MONOD
Cournil A, Eymard-Duvernay S, Diouf A and groupe d'etude de la cohorte A. [Bone aging and frailty
syndrome after 10 years of ARV treatment in Senegal]. Bull Soc Pathol Exot, 2014, 107, 238-40
Bulletin de la Societe de pathologie exotique, ANRS 1215
Cousien A, Obach D, Deuffic-Burban S, Mostafa A, Esmat G, Canva V, El Kassas M, El-Sayed M,
Anwar W A, Fontanet A, Mohamed M K and Yazdanpanah Y. Is expert opinion reliable when
estimating transition probabilities? The case of HCV-related cirrhosis in Egypt. BMC medical research
methodology, 2014, 14, 39 BMC medical research methodology, ANRS 12215
Coutherut J, Desclaux A and Groupe d'etude A. [Disclosing HIV status: the experience of PLHIV after
10 years of ARV treatment in Senegal]. Bull Soc Pathol Exot, 2014, 107, 266-72 Bulletin de la Societe
de pathologie exotique, ANRS 1215
Coutherut J and groupe d'etude de la cohorte A. [Socio-economic impact of one decade of ARV
therapy for people living with HIV in Senegal]. Bull Soc Pathol Exot, 2014, 107, 261-5 Bulletin de la
Societe de pathologie exotique, ANRS 1215
Danel C, Kabran M, Inwoley A, Badje A, Herrmann J L, Moh R, Lecarrou J, Gabillard D, Ntakpe J B,
Deschamps N, Ouattara E, Perronne C, Eholie S and Anglaret X. Quantiferon-TB Gold: performance
for ruling out active tuberculosis in HIV-infected adults with high CD4 count in Cote d'Ivoire, West
Africa. PLoS One, 2014, 9, e107245 PloS one, ANRS 12224
De Beaudrap P, Diouf A, Bousso Niang K and groupe d'etude de la Cohorte A. [Clinical and biological
effectiveness of antiretroviral therapy in the ANRS 1215 cohort]. Bull Soc Pathol Exot, 2014, 107, 2303 Bulletin de la Societe de pathologie exotique, ANRS 1215
Desclaux A. After the withdrawal of 'informed choice': the meanings and social effects of mothers'
choice for HIV prevention in Senegal. Anthropology & medicine, 2014, 21, 113-24 Anthropology &
medicine, ANRS 12271
Desclaux A, Boye S, Sow K and Ndoye T. [Experience of people living with HIV (PLHIV) on chronic
disease: a typology]. Bull Soc Pathol Exot, 2014, 107, 244-5 Bulletin de la Societe de pathologie
exotique, ANRS 1215
Desclaux A, Boye S and Taverne B. [The social relegation of widows living with HIV in the time of ART
in Senegal]. Bull Soc Pathol Exot, 2014, 107, 273-8 Bulletin de la Societe de pathologie exotique,
ANRS 1215
Desclaux A and Sow A. [Non-adaptation of people living with HIV (PLHIV) associations to people over
50]. Bull Soc Pathol Exot, 2014, 107, 279-80 Bulletin de la Societe de pathologie exotique, ANRS 1215
Diaw J, Taverne B and Coutherut J. [Sexual complaints and dysfunction among PLHIV receiving ARV
treatment for ten years in Senegal]. Bull Soc Pathol Exot, 2014, 107, 258-60 Bulletin de la Societe de
pathologie exotique, ANRS 1215
Diouf A, Cournil A and groupe d'etude de la Cohorte A. [Prevalence of metabolic complications after
10 years of antiretroviral treatment in Senegal]. Bull Soc Pathol Exot, 2014, 107, 234-7 Bulletin de la
Societe de pathologie exotique, ANRS 1215
Duffy D, Mamdouh R, Laird M, Soneson C, Le Fouler L, El-Daly M, Casrouge A, Decalf J, Abbas A,
Eldin N S, Fontes M, Abdel-Hamid M, Mohamed M K, Rafik M, Fontanet A and Albert M L. The ABCs
of viral hepatitis that define biomarker signatures of acute viral hepatitis. Hepatology, 2014, 59,
1273-82 Hepatology, ANRS 12210
Eholie S P, Vella S and Anglaret X. Commentary: Antiretroviral therapy initiation criteria in low
resource settings--from 'when to start' to 'when not to start'. AIDS, 2014, 28 Suppl 2, S101-4 Aids,
ANRS 12136
Ekouevi D K, Tchounga B K, Coffie P A, Tegbe J, Anderson A M, Gottlieb G S, Vitoria M, Dabis F and
Eholie S P. Antiretroviral therapy response among HIV-2 infected patients: a systematic review. BMC
Infect Dis, 2014, 14, 461 BMC infectious diseases,
Feray C, Bouscaillou J, Falissard B, Mohamed M K, Arafa N, Bakr I, El-Hoseiny M, Daly M E, ElKafrawy S, Plancoulaine S, Abdel-Hamid M, Thiers V and Fontanet A. A novel method to identify
routes of hepatitis C virus transmission. PLoS One, 2014, 9, e86098 PloS one, ANRS 1211 ANRS 12107
Goyet S, Lerolle N, Fournier-Nicolle I, Ken S, Nouhin J, Sowath L, Barennes H, Hak C, Ung C, Viretto
G, Delfraissy J F, Khuon P and Segeral O. Risk factors for hepatitis C transmission in HIV patients,
Hepacam study, ANRS 12267 Cambodia. AIDS Behav, 2014, 18, 495-504 AIDS and behavior, ANRS
12267 HEPACAM
Grinsztejn B, De Castro N, Arnold V, Veloso V G, Morgado M, Pilotto J H, Brites C, Madruga J V,
Barcellos N T, Santos B R, Vorsatz C, Fagard C, Santini-Oliveira M, Patey O, Delaugerre C, Chene G,
Molina J M and group A R T s. Raltegravir for the treatment of patients co-infected with HIV and
tuberculosis (ANRS 12 180 Reflate TB): a multicentre, phase 2, non-comparative, open-label,
randomised trial. Lancet Infect Dis, 2014, 14, 459-67 The Lancet. Infectious diseases,
Jean K, Gabillard D, Moh R, Danel C, Desgrees-du-Lou A, N'Takpe J B, Le Carrou J, Badje A, Eholie S,
Lert F, Anglaret X and Dray-Spira R. Decrease in sexual risk behaviours after early initiation of
antiretroviral therapy: a 24-month prospective study in Cote d'Ivoire. J Int AIDS Soc, 2014, 17, 18977
Journal of the International AIDS Society, ANRS 12239
Jean K, Gabillard D, Moh R, Danel C, Fassassi R, Desgrees-du-Lou A, Eholie S, Lert F, Anglaret X and
Dray-Spira R. Effect of early antiretroviral therapy on sexual behaviors and HIV-1 transmission risk
among adults with diverse heterosexual partnership statuses in Cote d'Ivoire. J Infect Dis, 2014, 209,
431-40 The Journal of infectious diseases, ANRS 12239
Kania D, Ottomani L, Meda N, Peries M, Dujols P, Bollore K, Renier W, Viljoen J, Ducos J, Van de
Perre P and Tuaillon E. Performance of two real-time PCR assays for hepatitis B virus DNA detection
and quantitation. J Virol Methods, 2014, 201, 24-30 Journal of virological methods, ANRS 12308/B 75
Kay A, Melo da Silva E, Pedreira H, Negreiros S, Lobato C, Braga W, Muwonge R, Deny P, Reis M,
Zoulim F, Trepo C, D'Oliveira A, Jr., Salcedo J M, Schinoni M I and Parana R. HBV/HDV co-infection in
the Western Brazilian Amazonia: an intriguing mutation among HDV genotype 3 carriers. J Viral
Hepat, 2014, 21, 921-4 Journal of viral hepatitis, ANRS 12259
Kouame G, Danel C, Moh R, Badje A, Jean K, N'Takpe J B, Gabillard D, Le Carrou J, du Lou A D,
Deschamps N, Eholie S and Anglaret X. WHO guidelines for antiretroviral therapy in serodiscordant
couples in sub-Saharan Africa: how many fit?, AIDS, 2014, 28, 1533-5 Aids, ANRS 12136
Laird M E, Mohsen A, Duffy D, Mamdouh R, LeFouler L, Casrouge A, El-Daly M, Rafik M, AbdelHamid M, Soulier A, Pawlotsky J M, Hezode C, Rosa I, Renard P, Mohamed M K, Bonnard P, Izopet
J, Mallet V, Pol S, Albert M L and Fontanet A. Apolipoprotein H expression is associated with IL28B
genotype and viral clearance in hepatitis C virus infection. J Hepatol, 2014, 61, 770-6 Journal of
hepatology, ANRS 12210
Lan N T, Thu N T, Barrail-Tran A, Duc N H, Lan N N, Laureillard D, Lien T T, Borand L, Quillet C,
Connolly C, Lagarde D, Pym A, Lienhardt C, Dung N H, Taburet A M and Harries A D. Randomised
pharmacokinetic trial of rifabutin with lopinavir/ritonavir-antiretroviral therapy in patients with HIVassociated tuberculosis in Vietnam. PLoS One, 2014, 9, e84866 PloS one, ANRS 12150
Larmarange J, Balestre E, Orne-Gliemann J, Iwuji C, Okesola N, Newell M L, Dabis F and Lert F. HIV
Ascertainment through Repeat Home-based Testing in the Context of a Treatment as Prevention Trial
(ANRS 12249 TasP) in Rural South Africa. AIDS Res Hum Retroviruses, 2014, 30 Suppl 1, A287 AIDS
research and human retroviruses,
Low A J, Konate I, Nagot N, Weiss H A, Kania D, Vickerman P, Segondy M, Mabey D, Pillay D, Meda
N, van de Perre P, Mayaud P and Yerelon Study G. Cervicovaginal HIV-1 shedding in women taking
antiretroviral therapy in Burkina Faso: a longitudinal study. J Acquir Immune Defic Syndr, 2014, 65,
237-45 Journal of acquired immune deficiency syndromes, ANRS 1222
Low A J, Konate I, Nagot N, Weiss H A, Mabey D, Segondy M, Vickerman P, Meda N, van de Perre P,
Mayaud P and Yerelon Cohort study g. Neisseria gonorrhoeae and Chlamydia trachomatis infection
in HIV-1-infected women taking antiretroviral therapy: a prospective cohort study from Burkina Faso.
Sex Transm Infect, 2014, 90, 100-3 Sexually transmitted infections, ANRS 1222
Marcy O, Laureillard D, Madec Y, Chan S, Mayaud C, Borand L, Prak N, Kim C, Lak K K, Hak C, Dim B,
Sok T, Delfraissy J F, Goldfeld A E, Blanc F X and Team C S. Causes and determinants of mortality in
HIV-infected adults with tuberculosis: an analysis from the CAMELIA ANRS 1295-CIPRA KH001
randomized trial. Clin Infect Dis, 2014, 59, 435-45 Clinical infectious diseases : an official publication
of the Infectious Diseases Society of America, ANRS 1295/ANRS 12160
Meresse M, March L, Kouanfack C, Bonono R C, Boyer S, Laborde-Balen G, Aghokeng A, SuzanMonti M, Delaporte E, Spire B, Carrieri M P, Laurent C and Stratall A E S G. Patterns of adherence to
antiretroviral therapy and HIV drug resistance over time in the Stratall ANRS 12110/ESTHER trial in
Cameroon. HIV Med, 2014, 15, 478-87 HIV medicine,
Monleau M, Aghokeng A F, Eymard-Duvernay S, Dagnra A, Kania D, Ngo-Giang-Huong N, ToureKane C, Truong L X, Chaix M L, Delaporte E, Ayouba A, Peeters M and Group A S. Field evaluation of
dried blood spots for routine HIV-1 viral load and drug resistance monitoring in patients receiving
antiretroviral therapy in Africa and Asia. J Clin Microbiol, 2014, 52, 578-86 Journal of clinical
microbiology,
Muller F and Taverne B. [Representations of therapeutic failure of ARV treatment among patients
and health care professionals in Dakar]. Bull Soc Pathol Exot, 2014, 107, 281-5 Bulletin de la Societe
de pathologie exotique, ANRS 1215
Ndoye I, Taverne B and Group A c S. Twelve years of follow-up for patients treated with ARVs in
Senegal (ANRS Cohort 1215): description of population and methodology. Bull Soc Pathol Exot, 2014,
107, 214-21 Bulletin de la Societe de pathologie exotique, ANRS 1215
Obach D, Deuffic-Burban S, Esmat G, Anwar W A, Dewedar S, Canva V, Cousien A, Doss W, Mostafa
A, Pol S, Buti M, Siebert U, Fontanet A, Mohamed M K and Yazdanpanah Y. Effectiveness and costeffectiveness of immediate versus delayed treatment of hepatitis C virus-infected patients in a
country with limited resources: the case of Egypt. Clin Infect Dis, 2014, 58, 1064-71 Clinical infectious
diseases : an official publication of the Infectious Diseases Society of America, ANRS 12215
Ouattara E N, Ross E L, Yazdanpanah Y, Wong A Y, Robine M, Losina E, Moh R, Walensky R P, Danel
C, Paltiel A D, Eholie S P, Freedberg K A and Anglaret X. Clinical impact and cost-effectiveness of
making third-line antiretroviral therapy available in sub-Saharan Africa: a model-based analysis in
Cote d'Ivoire. J Acquir Immune Defic Syndr, 2014, 66, 294-302 Journal of acquired immune deficiency
syndromes,
Peeters M, D'Arc M and Delaporte E. Origin and diversity of human retroviruses. AIDS reviews, 2014,
16, 23-34 AIDS reviews,
Plazy M, Dray-Spira R, Orne-Gliemann J, Dabis F and Newell M L. Continuum in HIV care from entry
to ART initiation in rural KwaZulu-Natal, South Africa. Trop Med Int Health, 2014, 19, 680-89 Tropical
medicine & international health : TM & IH, ANRS 12249 / B65
Rouet F, Kania D, Tuaillon E, Maiga A, Nouhin J, Rouzioux C, Descamps D and Plantier J C. Use of
reverse transcription-PCR-based assays for quantification of HIV-1 in dried blood spots requires
specific HIV-1 RNA isolation for monitoring of antiretroviral treatment efficiency. J Clin Microbiol,
2014, 52, 2740-1 Journal of clinical microbiology, ANRS 12186, ANRS 12235, AC12 Viro
Sanou A, Tarnagda Z, Kanyala E, Zingue D, Nouctara M, Ganame Z, Combary A, Hien H, Dembele M,
Kabore A, Meda N, Van de Perre P, Neveu D, Banuls A L and Godreuil S. Mycobacterium bovis in
Burkina Faso: epidemiologic and genetic links between human and cattle isolates. PLoS neglected
tropical diseases, 2014, 8, e3142 PLoS neglected tropical diseases, ANRS 12204
Sofeu C L, Warszawski J, Ateba Ndongo F, Penda I C, Tetang Ndiang S, Guemkam G, Makwet N,
Owona F, Kfutwah A, Tchendjou P, Texier G, Tchuente M, Faye A, Tejiokem M C and Group A-P S.
Low birth weight in perinatally HIV-exposed uninfected infants: observations in urban settings in
Cameroon. PLoS One, 2014, 9, e93554 PloS one, ANRS 12140, ANRS 12225
Sow K. [Childbearing in the era of antiretroviral drugs in Senegal, representations and practices
among PLHIV and health care professionals]. Bull Soc Pathol Exot, 2014, 107, 252-7 Bulletin de la
Societe de pathologie exotique, ANRS 1215
Taverne B, Desclaux A, Delaporte E and Ndoye I. [Long-term impact of antiretroviral therapy in
Africa: current knowledge]. Bull Soc Pathol Exot, 2014, 107, 222-9 Bulletin de la Societe de pathologie
exotique, ANRS 1215
Tchounga B K, Inwoley A, Coffie P A, Minta D, Messou E, Bado G, Minga A, Hawerlander D, Kane C,
Eholie S P, Dabis F, Ekouevi D K and Collaboration W. Re-testing and misclassification of HIV-2 and
HIV-1&2 dually reactive patients among the HIV-2 cohort of the West African Database to evaluate
AIDS collaboration. J Int AIDS Soc, 2014, 17, 19064 Journal of the International AIDS Society, ANRS
12294-B78
Veras J. Making tenofovir accessible in the brazilian public health system: patent conflicts and
generic production. Developing world bioethics, 2014, 14, 92-100 Developing world bioethics,
Zida S, Tarnagda Z, Kabore A, Zingue D, Hien H, Sanou A, Michel Gomgnimbou K, Nouctara M,
Ouedraogo M, Ouedraogo O, Godreuil S and Meda N. [Current status of atypical mycobacterial
infections in Burkina Faso: results of a regional survey]. The Pan African medical journal, 2014, 17,
188 The Pan African medical journal, ANRS 12204